Textbook of Clinical Management of Club Drugs and Novel Psychoactive Substances
Textbook of Clinical Management of Club Drugs and Novel Psychoactive Substances
Owen Bowden-Jones, Consultant Addiction Psychiatrist, Central and North West London NHS Foundation Trust
$85.00
USDThere are global concerns about the proliferation and misuse of club drugs and novel psychoactive substances, yet we know little about their harms and research on clinical management and treatment remains limited. This book fills the knowledge gap by providing a detailed overview of the research evidence available to date. The book provides a framework that allows readers to understand this large number of new drugs, using classifications based on primary psychoactive effect. Within this framework, the book provides detailed reviews of the more commonly used drugs. Each chapter explores pharmacology, patterns and mode of use, acute and chronic harms, and clinical interventions supported by research evidence. An invaluable resource for clinical staff, this book will support clinicians working in the emergency department, substance misuse and addiction services, mental health services, primary care, sexual health services and more. It will also be of interest to academics and those developing drug policy.
- Tackles a global public health issue and clinical challenges of rapidly changing drug patterns and limited knowledge of the harms of new psychoactive substances
- Provides a detailed summary of the up-to-date research evidence on the main club drugs and novel psychoactive substances
- Improves clinicians' ability to understand new substances that will emerge
- Offers authoritative and comprehensive guidance accessible to a wide range of clinicians and other practitioners working within substance misuse/addiction services, emergency departments, primary care, sexual health and mental health services
Reviews & endorsements
‘This book is a welcome addition to the previous 2015 NEPTUNE guidance. It provides a unique learning experience on what all clinicians should know about the misuse of club drugs and novel psychoactive substances. Capturing the latest trends of a dynamic drug market, the authors pulled together the best available evidence on a variety of substances to support the improvement of clinical practice. Whether you consult chapters of special interest or read the entire book, you can be assured that you will have been exposed to the most comprehensive work available on the clinical management of the harms of novel psychoactive substances. Highly recommended.’ Ornella Corazza, Ph.D., Professor of Addiction Science, University of Hertfordshire, UK, and President of the International Society for the Study of Emerging Drugs
‘The reader is here provided with unique, clear information on the treatment/management of NPS/club drug intake.’ Fabrizio Schifano, University of Hertfordshire, UK
Product details
October 2022Paperback
9781009182133
384 pages
245 × 187 × 18 mm
0.68kg
Available
Table of Contents
- 1. An Introduction to Club Drugs and Novel psychoactive substances
- 2. Psychosocial interventions for club drugs and novel psychoactive substances
- 3. Gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL) Drug group: depressants
- 4. New Benzodiazepine (BZD) NPS
- 5. Synthetic Opioids NPS (fentanyl and non-fentanyl NPS)
- 6. Ketamine and other NPS with dissociative effects
- 7. Nitrous oxide (N2O)
- 8. Stimulant Club Drugs and novel psychoactive substances
- 9. 'Ecstasy'- MDMA, 3,4-methylenedioxymethamphetamine), MDMA analogues and drugs with similar effects
- 10 . Methamphetamine
- 11. Synthetic cathinones
- 12. Hallucinogenic drugs
- 13. Synthetic cannabinoid receptor agonists (SCRA).
